Methicillin resistant Staphylococcus Aureus in emergency department patients in the United Arab Emirates

BMC Emergency Medicine
Muna Al JalafEric J Nilles

Abstract

Since the 1990s, community-associated methicillin resistant staphylococcus aureus (CA-MRSA) has emerged as an important global cause of skin and soft tissue infections. Little is known about the epidemiology of this pathogen in the Middle East. We conducted a prospective observational study in a single large teaching hospital in Dubai to identify the incidence of community-acquired methicillin resistant staphylococcus aureus (MRSA) among ambulatory patients presenting with purulent skin and soft tissue infections. We performed wound cultures and administered standard questionnaires to 100 cases presenting to the emergency department. Bivariate and multivariate analyses were performed to identify risk factors for MSRA versus other pathogens. The prevalence of MRSA was 23% (18/78) among 78 culture-positive isolates and 29% (18/62) among Staphylococcus-positive isolates. 74% received antibiotics of which 4/74 (5%) received antibiotics appropriate for CA-MRSA infections. Multivariate adjusted analysis identified playing contact sports (OR 5.9 [95% CI 1.3-27.1]) and female sex (OR 6.3 [95% CI 1.6-24.8]) as independent risks for MRSA infection. This is the first study to describe the epidemiology of CA-MRSA in the ambulatory setting ...Continue Reading

References

Mar 5, 1998·JAMA : the Journal of the American Medical Association·B C HeroldR S Daum
Apr 28, 2005·The Lancet Infectious Diseases·Nicola ZetolaWilliam R Bishai
Aug 18, 2006·The New England Journal of Medicine·Gregory J MoranUNKNOWN EMERGEncy ID Net Study Group
Dec 7, 2007·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·E E UdoA Al-Asar
Mar 31, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Munirih L QuallsDaniel J Pallin
Sep 11, 2012·Antimicrobial Resistance and Infection Control·Mahmoud Aly, Hanan H Balkhy
Mar 11, 2016·The New England Journal of Medicine·David A TalanGregory J Moran
Oct 26, 2016·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Abiola SenokStefan Monecke
Nov 1, 2016·The Journal of Antimicrobial Chemotherapy·C BouchiatUNKNOWN ESCMID Study Group on Staphylococci and Staphylococcal Infections (ESGS)

❮ Previous
Next ❯

Citations

Apr 3, 2019·Veterinary World·Nagham Mohammed AyyalDhuha Ismaeel Abdul-Majeed
Jul 23, 2019·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Sandra Valderrama-BeltránCesar A Arias
Feb 5, 2021·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Cindy Tiemi MatsumotoMarcelo Nascimento Burattini
Jul 1, 2021·Infection and Drug Resistance·Abiola SenokAlawi Alsheikh-Ali

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Cellulitis

Cellulitis (erysipelas) is a recurring and debilitating bacterial infection of the skin and underlying tissue. Discover the latest research on cellulitis here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.